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Edited by Christian GriesingerAbstract Catrocollastatin/vascular apoptosis-inducing protein
(VAP)2B is a metalloproteinase from Crotalus atrox venom,
possessing metalloproteinase/disintegrin/cysteine-rich (MDC)
domains that bear the typical domain architecture of a disintegrin
and metalloproteinase (ADAM)/adamalysin/reprolysin family
proteins. Here we describe crystal structures of catrocollasta-
tin/VAP2B in three diﬀerent crystal forms, representing the
ﬁrst reported crystal structures of a member of the monomeric
class of this family of proteins. The overall structures show
good agreement with both monomers of atypical homodimeric
VAP1. Comparison of the six catrocollastatin/VAP2B monomer
structures and the structures of VAP1 reveals a dynamic, modu-
lar architecture that may be important for the functions of
ADAM/adamalysin/reprolysin family proteins.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Metalloproteinase disintegrin; Apoptotic toxin1. Introduction
Hemorrhagic snake venoms induce local and systemic hem-
orrhaging by disrupting the walls of the blood vessels in enven-
omed patients [1]. In vitro, they induce apoptosis speciﬁcally in
cultured vascular endothelial cells [2]. Vascular apoptosis-
inducing protein (VAP)1 and VAP2 were originally isolated
from Crotalus atrox venom [3,4], and similar apoptotic toxins
have been isolated from other snake venoms [5–7]. VAP1 is a
disulﬁde-bridged homodimeric protein with an apparent
molecular weight of 110 kDa, and an isoelectric point of 8.5.
VAP2 is a single chain protein with a MW of 55 kDa and an
isoelectric point of 4.5 [3,4,8]. VAPs are members of the P-III
class of snake venom metalloproteinases (SVMPs), possessing
a metalloproteinase/disintegrin/cysteine-rich (MDC) domain
architecture typical of a disintegrin and metalloproteinase
(ADAM)/adamalysin/reprolysin family proteins [9,10]. VAP-
induced apoptosis is dependent on its catalytic activity [8], isAbbreviations: ADAM, a disintegrin and metalloproteinase; MDC,
Metalloproteinase/disintegrin/cysteine-rich; SVMP, Snake venom
metalloproteinase; HVR, Hyper-variable-region; ncs, Non-crystallo-
graphic symmetry; VAP, Vascular apoptosis-inducing protein; PEG,
Polyethyleneglycol
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doi:10.1016/j.febslet.2007.04.057inhibited by antibodies to integrins a3, a6, b1 and CD9 [11],
and involves activation of speciﬁc caspases [12]. However, the
physiological targets of VAPs and the underlying mechanism
of VAP-induced apoptosis remain elusive.
ADAMs are a family of mammalian membrane-anchored
glycoproteins that have been implicated in the processing of cell
surface and extracellular matrix proteins [13,14]. The crystal
structures of several P-I class SVMPs, which contain only a
metalloproteinase (M)-domain, and the isolated M and disinte-
grin/cysteine-rich (DC) domains of ADAMs have been deter-
mined [15–18]. However, structures of ADAM/adamalysin/
reprolysin family proteins that include the entire MDC domain
have not been determined. The relevance of the multidomain
structure to the catalytic and adhesive functions of this family
of proteins is an important issue that remains to be elucidated.
To better understand the structure–function relationship of
ADAM/adamalysin/reprolysin family proteins, and how it
relates to the molecular mechanism of VAP-induced apoptosis,
we have been engaged in crystallographic studies of VAPs.
Recently, we determined the crystal structure of VAP1, reveal-
ing the MDC domain architecture for the ﬁrst time [19].
Although the intrinsic two-fold symmetry of atypical homodi-
meric VAP1 conferred a great advantage for both its crystalli-
zation and structural resolution, the possibility remained that
the spatial arrangement of the MDC domains of VAP1 diﬀered
from that of monomeric SVMPs and ADAMs, due to crystal-
lographic restraints imposed on the molecule. The majority of
ADAMs and SVMPs do not to form VAP1-type dimers, most
likely due to the lack of a consensus QDHSK sequence [19] (res-
idues 320–324 in VAP1, in which the Nf atom of Lys324 is
coordinated by the six oxygen atoms of another monomer and
plays a pivotal role in dimer formation), and Cys365, which
are conserved among the dimeric SVMPs (Supplementary
Fig. 1). Therefore, to elucidate the general architecture of pro-
teins of the ADAM/adamalysin/reprolysin family, we crystal-
lized VAP2 and determined its structure. We modeled all of the
structures asmonomers ofVAP2B,which is identical to catrocol-
lastatin, a protein previously isolated as a platelet aggregation
inhibitor [20]. Here we describe the structure of catrocollastain/
VAP2B, as determined in three diﬀerent crystal forms. These
are the ﬁrst reported crystal structures of the monomeric class
of proteins in ADAM/adamalysin/reprolysin family.2. Materials and methods
Protein preparation and crystallization were performed as previ-
ously described [21]. The diﬀraction data sets were collected at theblished by Elsevier B.V. All rights reserved.
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detector with a wavelength of 1.0 A˚ at 100 K. Images were reduced
using HKL2000 [22] (Table 1). Structures were solved using the molec-
ular replacement (MR) method and the MOLREP program of the
CCP4 suite [23], with the structure of VAP1 (2ERO) as a starting mod-
el. The M- and C-domains of the VAP1 were used separately as the
search models. An MR solution was initially obtained from the Form
2-2 crystal data set, which assumed two M-domains and two C-do-
mains in the asymmetric units. After the model was manually rebuilt
using TURBO-FRODO [24], it was subjected to torsional molecular
dynamic reﬁnements using CNS [25]. Iterative reﬁnements and manual
rebuilding of the model improved the electron-density map and en-
abled us to model the remaining part of the molecule. The composite
omit electron-density maps created by CNS were used to conﬁrm the
chain tracing. After the polypeptide chains were modeled, we modeled
zinc and calcium ions and the inhibitor GM6001 (3-(N-hydroxycarb-
oxamide)-2-isobutyl-propanoyl-Trp-methylamide), then the compo-
nents of the carbohydrate chain linked to Asn371.
The two monoclinic crystal structures were solved by MR with the
domains of the reﬁned Form 2-2 crystal structure as a starting model.
In all three crystal forms, the asymmetric unit contained two mono-
mers of catrocollastatin/VAP2B. Reﬁnement statistics are shown in
Table 1. During the course of our analysis, we found a point mutation
(F203V) in the crystallized specimens. By comparing the structures
with that of VAP1, which has a phenylalanine at this position, we
determined that this mutation does not introduce a large structuralTable 1
Data collection and reﬁnement statistics
Form 2-1
Data collection
Space group P21
Cell dimensions
a, b, c (A˚) 56.9, 138.0, 59.2
a, b, c () 90, 91.5, 90
Resolution (A˚) (high resolution shell) 50–2.15(2.23–2.15)
No. of unique reﬂections 48664(4428)
aRmerge 0.081(0.196)
I/r(I) 9.8(4.6)
Completeness (%) 98.1(89.5)
Redundancy 3.3(2.0)
Reﬁnement
Resolution (A˚) (high resolution shell) 50–2.15(2.23–2.15)
No. of reﬂections 48628(4386)
bRwork 0.175(0.195)
cRfree 0.228(0.277)
Average B-factors (No. of atoms)
All atoms 19.9(7292)
Protein 18.5(6422)
Main chain atoms 17.2
Side chain atoms 19.9
Zn2+ 13.6(2)
Ca2+ 14.6(6)
Carbohydrate 54.2(139)
GM6001 16.2(56)
Water 26.5(668)
R.m.s deviations
Bond lengths (A˚) 0.0047
Bond angles () 1.20
Ramachandran plot
Most favored 87.2%
Additional allowed 12.1%
Generously allowed 0.4%
Disallowed 0.1%(R297B)
aRmerge = RhklRi j Ii(hkl)  Æ I(hlk)æj/RhklRiIi(hkl), where Ii(hkl) is the ith inten
bRwork =
P
iFobsj  jFcalci/
PjFobsj.
cRfree = R-value for a randomly selected subset (5%) of the data that were not
was used for measurement of each data set.change or aﬀect the ﬂexibility of the molecule. Graphical representa-
tions were prepared using the programs TURBO-FRODO [24], MOL-
SCRIPT [26], RASTER3D [27] and PyMOL [28].3. Results and discussion
3.1. Structural determination
Puriﬁed VAP2 was crystallized in variety of forms [21]. In
the current study, we determined the structures of three of
these crystal forms. Previously, we observed that the VAP2
preparation is a mixture of two homologous polypeptide
chains, VAP2A and VAP2B [29]. To identify the molecules
in the crystals as either VAP2A or catrocollastatin/VAP2B,
we carefully analyzed the composite omit electron-density
maps corresponding to the 11 amino acid residues that are dis-
tinct between the two proteins (Supplementary Fig. 1). Based
on this assessment, the major component in the three crystals
was determined to be catrocollastain/VAP2B. Therefore, in the
present study, we modeled all six molecules as catrocollastain/
VAP2B. The indole ring of GM6001 provided additionalForm 2-2 Form 2-5
P212121 C2
57.7, 118.2, 138.5 220.7, 79.5, 58.7
90, 90, 90 90, 91.7, 90
50–2.50(2.59–2.50) 50–2.70(2.80–2.70)
33288(2925) 26911(2313)
0.089(0.321) 0.085(0.231)
10.3(3.7) 10.1(5.5)
98.6(88.4) 95.9(82.5)
6.5(3.3) 3.4(2.8)
50–2.50(2.59–2.50) 50–2.70(2.80–2.70)
33099(2922) 26907(2276)
0.227(0.316) 0.199(0.264)
0.286(0.399) 0.260(0.328)
38.5(6801) 25.1(6823)
38.1(6438) 24.7(6438)
36.9 23.1
39.5 26.5
24.9(2) 18.7(2)
41.4(6) 21.5(6)
81.4(88) 37.4(226)
36.9(56) 0(-)
31.6(211) 22.2(151)
0.0065 0.0045
1.44 1.14
84.3% 82.8%
15.0% 16.4%
0.6% 0.4%
0.1%(R297B) 0.3%(R297A/R297B)
sity measurement of reﬂection hkl and ÆI(hlk)æ is its average.
used for minimization of the crystallographic residual. A single crystal
2418 T. Igarashi et al. / FEBS Letters 581 (2007) 2416–2422crystal contacts for the neighboring molecule, resulting in crys-
tals that were distinct from the inhibitor-free form.
3.2. Overall structure
The overall structure of catrocollastatin/VAP2B is presented
in Fig. 1. The structure of the M-domain was very similar to
the corresponding structures in adamalysin II [15] and
ADAM33 [17], with a ﬂat elliptical shape and a core formed
by a ﬁve-stranded b-sheet and four a-helices. A conserved
methionine (Met357, Met-turn) was present downstream of
the consensus HEXXHXXGXXHD sequence, which contains
three histidines (His333, His337 and His343) that function as
ligands of the catalytic zinc atom, and a glutamate residue
(Glu334) that functions as the general base (Fig. 2). These
structural features are typical of the metzincine family of
metalloproteinases [30,31]. A bound calcium ion was identiﬁed
opposite the active site cleft and close to the crossover point ofHVR
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Fig. 1. Ribbon diagrams of catrocollastatin/VAP2B. The M-domain,
linker, Ds, Da, Cw, and Ch segments and the HVRs are shown in red,
yellow, grey, cyan, pink, grey, green and blue, respectively. Zinc and
calcium ions are represented as red and black spheres, respectively. The
carbohydrate moiety linked to Asn371 is shown as a stick represen-
tation.the N- and C-terminal segments of the M-domain (Ca2+-bind-
ing site I), as in the structures of adamalysin II [15] and
ADAM33 [17]. The M-domain is followed by the D-domain,
which can be sub-divided into ‘‘shoulder’’ (Ds) and ‘‘arm’’
(Da) segments. Ds protrudes from the M-domain close to
Ca2+-binding site I, opposing the catalytic zinc atom. The C-
domain is sub-divided into ‘‘wrist’’ (Cw) and ‘‘hand’’ (Ch) seg-
ments. Because of its curved structure, with the concave sur-
face toward the M-domain, the distal portion of Ch comes
close to and faces the catalytic site, thus the entire molecule
adopts a C-shaped conformation. In the Ds and Da segments,
there are Ca2+ ions (sites II and III, respectively) that stabilize
the structure. Details of the Ca2+-coordinations are shown in
Supplementary Fig. 2. The distal portion of the C-shape, span-
ning residues 561–582 of the Ch domain, is the region in which
the amino acid sequence is most divergent and variable in
length among ADAM/adamalysin/reprolysin family proteins
(Fig. 2 and Supplementary Fig. 1). We designated this region
as the hyper-variable-region (HVR), and have proposed that
it represents a potential exosite for target recognition [19].
Aside from Cys377, whose side chain is embedded in the
hydrophobic core, all 34 cysteinyl residues are involved in
disulﬁde bonding. The number and spacing of cysteinyl resi-
dues, and the structures of the Ca2+-binding sites are strictly
conserved among ADAM/adamalysin/reprolysin family pro-
teins (Fig. 2 and Supplementary Fig. 1). Fig. 2 shows the se-
quence alignment of a selected subset of ADAMs and
SVMPs; alignment of the full sequences of catrocollastatin/
VAP2B and 107 proteins of the ADAM/adamalysin/reprolysin
family can be found in Supplementary Fig. 1.3.3. Flexible modular architecture
The structures of the M-domain (Fig. 3A), Ds (Fig. 3C), and
Cw/Ch (Fig. 3B) of the six catrocollastatin/VAP2B molecules
were nearly identical (r.m.s.d of 0.33, 0.45 and 0.59 A˚, respec-
tively). They were also essentially the same as the correspond-
ing regions of VAP1 (r.m.s.d of 0.78, 0.63 and 1.1 A˚,
respectively (Fig. 3A–C)). However, the relative orientations
of the sub-domains were quite variable. The largest diﬀerence
was observed when the M domains of the six catrocollastatin/
VAP2B molecules are superimposed. The Ds/Da/Cw/Ch por-
tion should be rotated by approximately 13 relative to the
M-domain, bringing about a 15-A˚ displacement at the distal
end of Ch (Fig. 3A). A similar plot of the Ch segments super-
imposed shows less hinge bending, bringing approximately a 6-
A˚ displacement at the distal portion of Ds (Fig. 3B). This con-
formed that the hinge motion occurs largely between the M
domain and Ds. The bending of the main chain at two residues,
Val403 and Gly438, is most prominent (Fig. 3C), however, the
entire linker region (which is deﬁned by the segment between
two structural Ca2+-binding sites, I and II) also moves in con-
cert with the bending motion of Val403 (Fig. 3D). In this con-
certed movement of the linker, the side chain of Leu408 in Ds
is positioned at a pivotal point (Fig. 3D and E). The main
chain carbonyl oxygen atom of Leu408 coordinates the cal-
cium ion at site II, whereas, the side-chain of Leu408 protrudes
from Ds and interacts with a small hydrophobic cavity on the
surface of the M domain (Fig. 3D). A balky hydrophobic res-
idue (Leu or Phe or Tyr) at this position is highly conserved
among ADAM/adamalysin/reprolysin family proteins (Sup-
plementary Fig. 1), and its side chain probably functions as
Fig. 2. Sequence alignment of catrocollastatin/VAP2B, VAP1 and human ADAMs. The cysteinyl residues and the conserved residues are shaded in
pink and yellow, respectively. Disulﬁde bridges, secondary structures and domains are drawn schematically. The HVR, Ca2+-binding sites, Zn2+-
binding site and disintegrin-loop are boxed in blue, red, green and cyan, respectively. The Ca2+-coordinating residues are shaded in red.
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ous orientations with respect to the M domain. The linker has
fewer speciﬁc interactions with Ds and has a rather high B-fac-
tor (Supplementary Figs. 3 and 4). It is divergent and variable
in length (7–12 aa), particularly in human ADAMs (Supple-
mentary Fig. 1), thus may function primarily in connecting
Ds to the M domain. The linker may also restrict the mobility
of the shoulder joint, and thus determine the preferred orienta-
tion of the M domain of each ADAMs relative to the rest of
the molecule for distinct targets. The residues forming the
hydrophobic cavity with which Leu408 interacts are less con-
served and also have relatively high B-factors (Supplementary
Figs. 3 and 4). Thus they may also contribute to the ﬂexibility
of the shoulder joint.
Previously, we suggested a putative mechanism of HVR-
mediated target recognition and catalysis by this family of pro-
teins [19]. The present study allows us to incorporate into the
previous model that intrinsic ﬂexibility may be important for
ﬁne-tuning substrate recognition, by adjusting the spatial
alignment of the catalytic and adhesion sites during the cata-
lytic cycle (Fig. 3F). The structure of the lower half of the
Da segment in catrocollastatin/VAP2B was diﬀerent from that
of VAP1 (Fig. 3B and Supplementary Fig. 3C), most likely due
to the substitution of Glu470 (in catrocollastain/VAP2B) with
Asp471 (in VAP1), and the insertion of Pro480 (in catrocolla-
stain/VAP2B). All the ADAMs, with the exception of ADAMs
10 and 17, which lack Ca2+-binding site III, and the mono-
meric P-III and P-IV SVMPs contain Glu470 and Pro480
(see Supplementary Fig. 1). Thus, it is likely that they adopt
a more catrocollastatin/VAP2B-like structure. As was ob-
served in VAP1, the disintegrin-loop is packed by Cw, and
forms a less ﬂexible Da/Cw junction, and therefore is unavail-
able for ligand binding. Diﬀerences in the orientation of Da
and Cw among these proteins may be important for proper
spatial alignment of the catalytic and adhesion units and for
substrate binding speciﬁcity. The angle between Cw and Chin catrocollastatin/VAP2B was nearly invariant. It was essen-
tially the same as that seen in VAP1 (Fig. 3B), but substan-
tially diﬀerent than that of ADAM10 [18,19]. Whether
diﬀerent ADAM/adamalysin/reprolysin family proteins have
distinct Cw/Ch orientations remains to be established.
3.4. Modular architecture and post-translational processing
The disintegrins that are commonly found in Viperid ven-
oms are typically generated by proteolytic processing of larger
precursor molecules, the P-II class of SVMPs, which contain
an M-domain plus a disintegrin portion [32,33]. The ﬂexible
modular structure described above points to a potential mech-
anism of selection of cleavage sites for this processing event.
The cleavage sites of the medium-sized disintegrins (70 ami-
no acids) are usually within Ca2+-binding site II, whereas,
those of the shorter ones (41–51 residues) are at the boundary
between Ds and Da. The longer disintegrins (84 residues) are
processed within the linker between M and Ds (Fig. 4 and Sup-
plementary Fig. 1). Most of the P-II SVMPs have fewer cys-
teine residues within their Ds segment (3 or 5 cysteine
residues, see Supplementary Fig. 1) compared to P-III SVMPs,
and thus have fewer disulﬁde bonds. Additionally, they con-
tain substitutions of the calcium-binding residues at site II,
indicating that they have a less stable Ds structure compared
to P-III SVMPs. Long disintegrins have the same number of
cysteine residues (7 cysteine residues) and Ca2+-binding resi-
dues at site II as P-III SVMPs and ADAMs, and thus would
be predicted to have a more stable Ds structure, which may ac-
count for their cleavage at the linker between M and Ds. A
protective role for calcium against auto proteolysis in the lin-
ker region has been reported [34], and the linker region is usu-
ally removed from P-I SVMPs post-translationally [35].
Collectively, these observations suggest that diﬀerential sus-
ceptibility to proteolysis in the linker region and Ds, due to
variability in the number of disulﬁde bonds and the presence
or absence of bound calcium at site II, may underlie the
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Fig. 3. Mobility of the sub-domains. (A) The M-domains of the six catrocollastatin/VAP2B molecules and the VAP1 monomer were superimposed
and are shown in stereo. Two representative catrocollastatin/VAP2B molecules are shown in blue and red, the other four catrocollastatin/VAP2B
molecules are in gray, and the VAP1 monomer is in green. The zinc ion is shown as a yellow sphere. The calcium atoms bound to the red and blue
catrocollastatin/VAP2B molecule and VAP1 are shown as red, blue and green spheres, respectively. Superimposition of the Dh and Cs segments of the
six catrocollastatin/VAP2B molecules and the VAP1 monomer are shown in B and C, respectively. (D) Close-up view of the shoulder joint. The
molecular surface of the M-domain is colored according to the electrochemical surface potential (red to blue). The linker and part of the Ds segment
of the two representative catrocollastatin/VAP2B molecules are shown as stick representations in pink and cyan, respectively. (E) Schematic diagram
of the hinge motion at the shoulder joint. (F) Schematic model of substrate recognition and cleavage by a soluble ADAM/adamalysin/reprolysin
protein.
2420 T. Igarashi et al. / FEBS Letters 581 (2007) 2416–2422generation of disintegrins with diﬀerent lengths. Fertilin a
(ADAM1) and b (ADAM2) undergo proteolytic processing
within Ca2+-binding site III and the linker region, respectivelyat diﬀerent stages of sperm maturation (Fig. 4, Supplementary
Fig. 1) [36,37]. The current structural data suggests that Ca2+-
binding, together with a ﬂexible modular structure, may also
Fig. 4. Schematic representation of the modular architecture of ADAM/adamalysin/reprolysin family proteins. Each sub-domain is colored as for
Fig. 1; the pro-domain (Pro), EGF-like domain (EGF), transmembrane region (TM) and cytoplasmic domain (CT) are in black, yellow, black and
light salmon, respectively. The RGD sequences in disintegrins and an interchain disulﬁde bond in VAP1 are indicated. The Zn2+ and Ca2+ ions are
shown as red and black circles, respectively; the closed circles indicate that all the members have a complete metal-binding sequence, whereas, open
circles indicate that some members do not have it.
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proteins, giving rise to the biochemical and functional com-
plexity of Crotalid and Viperid snake venoms, as well as
post-translational regulation of ADAMs’ functions.4. Conclusion
ADAMs are widely distributed and constitute major mem-
brane-bound sheddases that proteolytically process cell-sur-
face-proteins for cell–cell communication. As such, they have
emerged as potential therapeutic targets for a variety of dis-
eases. SVMPs are key toxins involved in venom-induced path-
ogenesis, and thus are important targets for antivenom
therapeutics. However, the physiological targets of ADAMs
and SVMPs, and the molecular mechanism of target recogni-
tion are poorly understood. The structures presented here re-
veal a dynamic, modular architecture of the MDC domains
of ADAM/adamalysin/reprolysin family proteins. Intrinsic
ﬂexibility may be important for ﬁne-tuning substrate recogni-
tion, adjusting the spatial alignment of the catalytic and adhe-
sion sites, and for post-translational regulation of this family
of proteins.
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Japan.Appendix A. Supplementary data
The atomic coordinates and structure factors have been
deposited in the Protein Data Bank under accession codes
2DW0, 2DW1 and 2DW2 for the Form 2-1, Form 2-2 and
Form 2-5 crystals, respectively. Supplementary data associated
with this article can be found, in the online version, at
doi:10.1016/j.febslet.2007.04.057.
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